Mirum Pharmaceuticals, Inc. (FRA:08D)
Germany
· Delayed Price · Currency is EUR 58.00
-1.00 (-1.69%)
At close: Dec 5, 2025
Mirum Pharmaceuticals Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2018 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2018 |
| Net Income | -41.42 | -87.94 | -163.42 | -135.67 | -83.99 | -103.27 | Upgrade
|
| Depreciation & Amortization | 25.58 | 24.98 | 11.45 | 3.68 | 0.6 | 0.62 | Upgrade
|
| Other Amortization | 1.72 | 1.66 | 1.12 | - | - | - | Upgrade
|
| Loss (Gain) From Sale of Assets | - | - | - | - | -108 | - | Upgrade
|
| Loss (Gain) From Sale of Investments | - | - | - | - | -0.14 | 0.07 | Upgrade
|
| Stock-Based Compensation | 65.65 | 48.44 | 35.02 | 27.01 | 23.09 | 12.55 | Upgrade
|
| Other Operating Activities | 0.56 | 0.59 | 64.1 | 5.89 | 18.7 | 0.34 | Upgrade
|
| Change in Accounts Receivable | -39.91 | -11.43 | -43.97 | -20.73 | - | - | Upgrade
|
| Change in Inventory | -6.38 | -3.17 | -0.97 | -3.45 | -0.5 | - | Upgrade
|
| Change in Accounts Payable | 56 | 40.31 | 30.78 | 7.64 | 22.66 | 3.68 | Upgrade
|
| Change in Other Net Operating Assets | -17.1 | -3.13 | -5.05 | -4.51 | -5.18 | -3.07 | Upgrade
|
| Operating Cash Flow | 44.69 | 10.33 | -70.94 | -120.14 | -132.76 | -89.08 | Upgrade
|
| Capital Expenditures | -0.37 | -0.99 | -0.11 | -0.28 | -0.02 | -0.23 | Upgrade
|
| Cash Acquisitions | - | - | -212.76 | - | - | - | Upgrade
|
| Sale (Purchase) of Intangibles | - | -20 | -20 | - | -19 | - | Upgrade
|
| Investment in Securities | -23.95 | -69.13 | 125.67 | 7.98 | -40.43 | 38.1 | Upgrade
|
| Other Investing Activities | - | - | - | - | 108 | - | Upgrade
|
| Investing Cash Flow | -24.32 | -90.13 | -107.2 | 7.7 | 48.55 | 37.87 | Upgrade
|
| Long-Term Debt Issued | - | - | 305.3 | - | - | - | Upgrade
|
| Total Debt Issued | - | - | 305.3 | - | - | - | Upgrade
|
| Net Debt Issued (Repaid) | - | - | 305.3 | - | - | - | Upgrade
|
| Issuance of Common Stock | 36.48 | 17.7 | 227.15 | 114.64 | 9.01 | 131.87 | Upgrade
|
| Other Financing Activities | - | - | -195.86 | -5.55 | 64.45 | 49.42 | Upgrade
|
| Financing Cash Flow | 36.48 | 17.7 | 336.6 | 109.09 | 73.47 | 181.29 | Upgrade
|
| Foreign Exchange Rate Adjustments | 2.25 | -1.3 | -0.13 | 0.01 | -0 | 0.03 | Upgrade
|
| Net Cash Flow | 59.11 | -63.4 | 158.32 | -3.34 | -10.75 | 130.12 | Upgrade
|
| Free Cash Flow | 44.32 | 9.33 | -71.05 | -120.41 | -132.78 | -89.3 | Upgrade
|
| Free Cash Flow Margin | 9.39% | 2.77% | -38.12% | -156.26% | -693.81% | - | Upgrade
|
| Free Cash Flow Per Share | 0.90 | 0.20 | -1.74 | -3.54 | -4.38 | -3.54 | Upgrade
|
| Cash Interest Paid | 12.65 | 12.65 | 6.82 | - | - | - | Upgrade
|
| Cash Income Tax Paid | 2.38 | 1 | 0.13 | - | - | 0.01 | Upgrade
|
| Levered Free Cash Flow | 48.71 | 18.02 | -90.73 | -68.13 | -96.18 | -49.12 | Upgrade
|
| Unlevered Free Cash Flow | 55.97 | 25.3 | -82.41 | -58.14 | -85.19 | -48.91 | Upgrade
|
| Change in Working Capital | -7.39 | 22.59 | -19.22 | -21.05 | 16.98 | 0.61 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.